Please assess the completion status of the following clinical trial:

Trial Title: Pioglitazone Therapy for Chronic Granulomatous Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age：1 months to 18 years~2. Chronic Granulomatous Disease~3. with severe infections~Exclusion Criteria:~1. \> 18 years of age~2. infections are treatable by conventional therapy (antibiotics, antimycotics, allogeneic granulocytes)

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Pioglitazone (Type: EXPERIMENTAL): Treatment for chronic granulomatous disease patients with severe infection.

Based on this trial design, predict the completion outcome and termination type (if applicable).